PE20030071A1 - Capsulas para inhalacion - Google Patents

Capsulas para inhalacion

Info

Publication number
PE20030071A1
PE20030071A1 PE2002000465A PE2002000465A PE20030071A1 PE 20030071 A1 PE20030071 A1 PE 20030071A1 PE 2002000465 A PE2002000465 A PE 2002000465A PE 2002000465 A PE2002000465 A PE 2002000465A PE 20030071 A1 PE20030071 A1 PE 20030071A1
Authority
PE
Peru
Prior art keywords
humidity
starch
capsule
inhalation
inhalation capsules
Prior art date
Application number
PE2002000465A
Other languages
English (en)
Spanish (es)
Inventor
Dieter Hochra Iner
Karoline Bechtold-Peters
Michael Walz
Michael Trunk
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7687020&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20030071(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of PE20030071A1 publication Critical patent/PE20030071A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001—Particle size control
    • A61M11/003—Particle size control by passing the aerosol trough sieves or filters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PE2002000465A 2001-06-01 2002-05-31 Capsulas para inhalacion PE20030071A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10126924A DE10126924A1 (de) 2001-06-01 2001-06-01 Inhalationskapseln

Publications (1)

Publication Number Publication Date
PE20030071A1 true PE20030071A1 (es) 2003-03-04

Family

ID=7687020

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2002000465A PE20030071A1 (es) 2001-06-01 2002-05-31 Capsulas para inhalacion

Country Status (37)

Country Link
EP (2) EP1379220B1 (enExample)
JP (3) JP4447311B2 (enExample)
KR (2) KR100921904B1 (enExample)
CN (3) CN101829072A (enExample)
AR (2) AR034346A1 (enExample)
AT (1) ATE285752T1 (enExample)
AU (2) AU2002344354B2 (enExample)
BG (1) BG65655B1 (enExample)
BR (1) BR0209366A (enExample)
CA (1) CA2448425C (enExample)
CH (1) CH1379220H1 (enExample)
CO (1) CO5540379A2 (enExample)
CZ (1) CZ300284B6 (enExample)
DE (2) DE10126924A1 (enExample)
EA (1) EA005188B1 (enExample)
EC (2) ECSP034868A (enExample)
EE (1) EE05416B1 (enExample)
EG (1) EG24227A (enExample)
ES (1) ES2236590B5 (enExample)
HR (1) HRP20030993B1 (enExample)
HU (3) HU230058B1 (enExample)
IL (2) IL158917A0 (enExample)
ME (1) ME00301B (enExample)
MX (1) MXPA03010990A (enExample)
MY (1) MY126253A (enExample)
NO (1) NO332857B3 (enExample)
NZ (1) NZ530356A (enExample)
PE (1) PE20030071A1 (enExample)
PL (2) PL205714B1 (enExample)
PT (1) PT1379220E (enExample)
RS (1) RS50353B (enExample)
SI (1) SI1379220T1 (enExample)
SK (2) SK287379B6 (enExample)
TW (1) TWI327921B (enExample)
UA (1) UA75659C2 (enExample)
WO (1) WO2002098874A2 (enExample)
ZA (1) ZA200308340B (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1712A (en) 2000-10-12 2007-01-24 Boehringer Ingelheim Pharma Novel tiotropium-containing inhalation powder
DE10126924A1 (de) * 2001-06-01 2002-12-05 Boehringer Ingelheim Pharma Inhalationskapseln
DE10212264A1 (de) 2002-03-20 2003-10-02 Boehringer Ingelheim Pharma Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
EP1501479A1 (en) * 2002-05-07 2005-02-02 Nektar Therapeutics Capsules for dry powder inhalers and methods of making and using same
US7763280B2 (en) 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
DE10255387A1 (de) * 2002-11-28 2004-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Tiotropium-haltige Pulverformulierung für die Inhalation
DE10258360A1 (de) * 2002-12-12 2004-06-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverinhalator mit Kapselkammer zum Aufnehmen einer mit Wirkstoff gefüllten Einwegkapsel
DE10352277A1 (de) 2003-11-08 2005-06-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverinhalator
SE0303570L (sv) 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
SE0303269L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Medicinsk produkt
GB0503738D0 (en) 2005-02-23 2005-03-30 Optinose As Powder delivery devices
RU2369411C2 (ru) * 2005-04-21 2009-10-10 Бёрингер Ингельхайм Интернациональ Гмбх Порошковый ингалятор
US7694676B2 (en) 2005-04-22 2010-04-13 Boehringer Ingelheim Gmbh Dry powder inhaler
JP4825455B2 (ja) * 2005-05-02 2011-11-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 粉末吸入器
DE102006016904A1 (de) 2006-04-11 2007-10-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalator
DE102006016901A1 (de) 2006-04-11 2007-10-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Mundstück für einen Inhalator
GB0716026D0 (en) 2007-08-16 2007-09-26 Norton Healthcare Ltd An inhalable medicament
DE102007036411A1 (de) 2007-07-20 2009-02-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverinhalator
DE102007052871A1 (de) * 2007-11-02 2009-05-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Kapsel zur Aufnahme von pharmazeutischen Wirkstoffformulierungen
EP2244686A1 (de) * 2008-02-08 2010-11-03 Boehringer Ingelheim International GmbH Verfahren und vorrichtung zur befüllung von kapseln
EP2172190A1 (en) * 2008-10-02 2010-04-07 Laboratorios Liconsa, S.A. Inhalable particles comprising tiotropium
ES2739352T3 (es) 2009-02-26 2020-01-30 Glaxo Group Ltd Formulaciones farmacéuticas que comprenden 4-{(1R)-2-[(6-{2-[(2,6-diclorobencil)oxi]etoxi}hexil)amino]-1-hidroxietil}-2-(hidroximetil)fenol
WO2010110760A1 (en) * 2009-03-27 2010-09-30 Mahmut Bilgic Compositions comprising water with deuterium for the prevention or treatment of allergic diseases and a process for the preparation thereof
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
EP2575786B1 (en) 2010-06-03 2017-11-15 Sima Patent ve Lisanslama Hizmetleri Ltd.Sti. Process for dry powder formulations
DE202011102694U1 (de) 2011-06-29 2011-12-19 Zisser Gmbh Inhalationsgerät für Heimanwender
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
EA036153B1 (ru) 2012-07-05 2020-10-06 Арвен Айлак Санайи Ве Тиджарет А.С. Фармацевтическая композиция для ингаляции, упакованная дозированная форма, капсула, способ лечения обструктивных заболеваний дыхательных путей и фармацевтический набор
DE202013000774U1 (de) 2013-01-21 2013-04-15 Rhinofilt GmbH Miniaturisiertes Inhalationsgerät zur Privatanwendung
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
CN108295042A (zh) * 2018-03-05 2018-07-20 上海祺宇生物科技有限公司 一种用于吸入药剂的植物空心胶囊及其胶囊剂
CN108451920A (zh) * 2018-03-14 2018-08-28 绍兴康可胶囊有限公司 一种吸雾式胶囊及其制备方法
CN114848605B (zh) * 2022-03-25 2023-08-11 上海方予健康医药科技有限公司 一种供吸入粉雾剂用的明胶胶囊

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
WO1993025193A1 (fr) * 1992-06-12 1993-12-23 Teijin Limited Preparation pharmaceutique destinee a etre administree par les voies respiratoires
US6228394B1 (en) * 1997-10-14 2001-05-08 Boehringer Ingelheim Pharmaceuticals, Inc. Supercritical fluid extraction of mould lubricant from hard shell capsules
DE19835346A1 (de) * 1998-08-05 2000-02-10 Boehringer Ingelheim Pharma Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
JP2000143502A (ja) * 1998-11-11 2000-05-23 Shionogi Qualicaps Kk 吸入製剤
CN1150895C (zh) * 1998-11-13 2004-05-26 杰格研究股份公司 用于吸入给药的干粉
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
EP1072258A1 (de) * 1999-07-28 2001-01-31 Greither, Peter Eine Kapsel für die Freisetzung von Bakterien, enthaltend ein Bakterienlyophilisat und ein Verfahren zu ihrer Herstellung
AU7685200A (en) * 1999-10-12 2001-04-23 Kaken Pharmaceutical Co., Ltd. Powdery inhalational preparations and process for producing the same
DE10126924A1 (de) * 2001-06-01 2002-12-05 Boehringer Ingelheim Pharma Inhalationskapseln

Also Published As

Publication number Publication date
SK287379B6 (sk) 2010-08-09
PT1379220E (pt) 2005-03-31
JP4447311B2 (ja) 2010-04-07
KR100921904B1 (ko) 2009-10-16
RS50353B (sr) 2009-11-10
AU2008203057B2 (en) 2011-12-08
JP4787034B2 (ja) 2011-10-05
KR100952321B1 (ko) 2010-04-09
SK16202003A3 (sk) 2004-05-04
AU2008203057C1 (en) 2017-05-18
NZ530356A (en) 2005-05-27
CZ20033579A3 (en) 2004-05-12
JP2006143747A (ja) 2006-06-08
AR084804A2 (es) 2013-06-26
PL205714B1 (pl) 2010-05-31
CN101697965A (zh) 2010-04-28
EE05416B1 (et) 2011-06-15
HRP20030993A2 (en) 2005-08-31
BR0209366A (pt) 2004-06-08
SI1379220T1 (sl) 2005-04-30
ECSP11004868A (es) 2011-02-28
CZ300284B6 (cs) 2009-04-08
HUP1500188A2 (en) 2005-03-29
EG24227A (en) 2008-11-10
ES2236590B5 (es) 2018-03-05
CO5540379A2 (es) 2005-07-29
EP1379220A2 (de) 2004-01-14
ES2236590T3 (es) 2005-07-16
EA200301275A1 (ru) 2004-06-24
PL203801B1 (pl) 2009-11-30
HU230827B1 (hu) 2018-07-30
BG65655B1 (bg) 2009-05-29
BG108380A (bg) 2004-11-30
EA005188B1 (ru) 2004-12-30
AU2008203057A1 (en) 2008-07-31
KR20090010140A (ko) 2009-01-28
DE50201898D1 (de) 2005-02-03
NO332857B3 (no) 2016-01-25
PL387118A1 (pl) 2004-12-13
HU230058B1 (hu) 2015-06-29
ZA200308340B (en) 2004-05-21
SK287346B6 (sk) 2010-07-07
MY126253A (en) 2006-09-29
WO2002098874A2 (de) 2002-12-12
CA2448425A1 (en) 2002-12-12
EE200300595A (et) 2004-02-16
AU2002344354B2 (en) 2008-08-07
IL158917A (en) 2008-11-03
CN1512875A (zh) 2004-07-14
YU93503A (sh) 2006-05-25
ME00301B (me) 2011-05-10
NO332857B1 (no) 2013-01-21
HU231082B1 (hu) 2020-06-29
CN101829072A (zh) 2010-09-15
WO2002098874A3 (de) 2003-09-12
MXPA03010990A (es) 2004-02-27
ATE285752T1 (de) 2005-01-15
MEP42508A (en) 2011-02-10
AU2008203057C8 (en) 2017-04-06
IL158917A0 (en) 2004-05-12
NO20035265D0 (no) 2003-11-27
UA75659C2 (en) 2006-05-15
ECSP034868A (es) 2004-03-23
JP2008050364A (ja) 2008-03-06
TWI327921B (en) 2010-08-01
EP1508330A1 (de) 2005-02-23
CA2448425C (en) 2010-12-21
KR20040007638A (ko) 2004-01-24
HUP0400666A3 (en) 2009-06-29
CH1379220H1 (enExample) 2018-10-31
NO20035265L (no) 2003-11-27
PL364108A1 (en) 2004-12-13
HUP0400666A2 (hu) 2005-03-29
DE10126924A1 (de) 2002-12-05
AR034346A1 (es) 2004-02-18
HRP20030993B1 (en) 2011-10-31
EP1379220B1 (de) 2004-12-29
JP2005500279A (ja) 2005-01-06

Similar Documents

Publication Publication Date Title
CY1106033T1 (el) Μεθοδοι κατepγασιας καψουλων και ξηρων, κονιοποιημενων φαρμακευτικων τυποποιησεων
ECSP941148A (es) Medicamento en forma de comprimido con liberacion retardada de substancia activa
AR084804A2 (es) Capsulas para inhalacion
MXPA05006253A (es) Mejoras relacionadas con articulos para fumar.
EA200702187A1 (ru) Композиция таблетки прамипексола с замедленным высвобождением
JP2003135107A5 (enExample)
ES2139255T3 (es) Lengueta de fijacion.
ES2181417T3 (es) Formulacion de capsulas o tabletas de efavirenz de disolucion rapida usando super-desintegrantes.
ES2163383T1 (es) Compuestos de fibra celulosica.
ATE226815T1 (de) Herstellung von arzneimitteln
DE69931498D1 (de) Oral zersetzbare tablette mit ausbildung eines zähen schleims
BR0308378A (pt) Composição veterinária sólida com o paladar mascarado
ES2107527T3 (es) Capsulas de gelatina sustituida por almidon de alto contenido en amilosa.
BR0214795A (pt) Matrizes compósitas biocompatìveis conpreendendo colágeno e elastina
IT1277395B1 (it) Procedimento per la produzione di calze o simili a punta chiusa con una macchina circolare monocilindrica
BR9815466A (pt) Cápsulas comestìveis com revestimentos com sabor
DE60320661D1 (de) System mit kontrollierter freisetzung bioaktiver wirkstoffe
ES2146873T3 (es) Dispositivo para mezclar al menos dos componentes de plastico quimicamente reactivos.
TR200402419T4 (tr) Okskarbazepin içeren süspansiyon.
KR900002728A (ko) 개선된 흡연 물품
DK0892852T3 (da) Indkapslede celler, som udtrykker cytochrom-P450 til pro-drug-aktivering
ES2188555T3 (es) Cigarrillo con filtro de tabaco.
ATE278394T1 (de) Verabreichungskapseln
DE69917658D1 (de) Micronisierte pharmazeutische zusammensetzungen
Sarv Finds of leather footwear from the excavations at Sauna Street 10 in Tallinn: Nahkjalatsid Tallinnast Sauna tänav 10 arheoloogiliste kaevamiste leiumaterjalis

Legal Events

Date Code Title Description
FG Grant, registration